Thank you for listening to The Chemical Sensitivity Podcast!
New episodes twice a month. Subscribe on Apple Podcasts, Spotify, Google Podcasts, or wherever you get your podcasts to never miss one.
And follow on social media for all updates.
This episode features a conversation with Maya Dusenbery.
Maya is the author of the extraordinary book, "Doing Harm: The Truth About How Bad Medicine and Lazy Science Leave Women Dismissed, Misdiagnosed, and Sick."
Maya talks about why so many women with chronic illnesses, including MCS, are often dismissed and misdiagnosed. And how women's knowledge is a source of power.
I hope you enjoy the conversation.
If there's someone you would like to hear interviewed on the podcast or a topic you would like us to explore, please let me know. Email: info@chemicalsensitivitypodcast.org.
Thanks again for listening!
DISCLAIMER: THIS PODCAST AND WEBSITE DO NOT PROVIDE MEDICAL ADVICE
The information, including but not limited to, text, graphics, images, and other material contained on this website are for informational purposes only. No material on this site is intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website. No material or information provided by The Chemical Sensitivity Podcast, or its associated website is intended to be a substitute for professional medical advice, diagnosis, or treatment.
Thank you very much to the Marilyn Brachman Hoffman Foundation generously supporting the podcast!
If you find the podcast helpful, please consider becoming a supporter!
https://buymeacoffee.com/mcspodcast
Follow the podcast on YouTube! Captions available in any language.
Please follow the podcast on social media:
Facebook
X
Instagram
BlueSky
TikTok
